Print this page    •   Back to Web version of article

An Overview of Intelence (TMC125, Etravirine)

August 23, 2013

IntelenceIntelence

Brand Name: Intelence
Other Name(s): ETR
Drug Class: Non-nucleoside Reverse Transcriptase Inhibitors
Approved Use: Treatment of HIV Infection

WARNING:

Etravirine can cause serious, life-threatening side effects. These include severe rash and allergic reactions.

Contact your health care provider right away if you have a rash. Stop taking etravirine and contact your health care provider right away if you have a rash along with any of the following symptoms:

While taking etravirine, it is important to keep all of your appointments with your health care provider.


What is etravirine?

Etravirine is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children 6 years of age and older.

Etravirine is a type of anti-HIV medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI). NNRTIs work by binding to and blocking HIV reverse transcriptase, an HIV enzyme. This prevents HIV from replicating and lowers the amount of HIV in the blood.

Etravirine is always used in combination with other anti-HIV medicines. Etravirine is used only in people who are already taking or have taken an NNRTI plus other anti-HIV medicines and in whom these medicines are not controlling their HIV infection.

Etravirine does not cure HIV/AIDS. It is not known if etravirine reduces the risk of passing HIV to other people.


What should I tell my health care provider before taking etravirine?

Before taking etravirine, tell your health care provider:


How should I take etravirine?

Etravirine comes in tablet form in three different strengths:

Take etravirine according to your health care provider's instructions.

Advertisement

Always take etravirine after a meal. Do not take etravirine on an empty stomach. Swallow the tablets whole with a glass of water. Do not chew the tablets.

If you are unable to swallow the etravirine tablets whole, place the tablets in a glass containing a teaspoon of water. (If needed, add more water to cover the tablets.) Do not put the tablets in other liquids. Stir well until the water looks milky. At this step, you may add a small amount of water, orange juice, or milk to make the mixture easier to drink. Then drink the mixture right away. Rinse the glass with water, orange juice, or milk several times, and completely swallow the rinse each time to make sure you take the entire dose of etravirine. Avoid using grapefruit juice or warm (104°F/40°C) or carbonated beverages when taking etravirine tablets.

Always take etravirine in combination with other anti-HIV medicines.

If you take too much etravirine, contact your local poison control center (1-800-222-1222) or go to the nearest hospital emergency room right away.

For more information on how to take etravirine, see the FDA drug label from DailyMed. (DailyMed is a federal website that includes the most recent drug labels submitted to FDA.)


What should I do if I forget a dose?

If you miss a dose within 6 hours of the time you usually take it, take your dose after a meal as soon as possible. Then take your next dose at the regularly scheduled time. If you miss a dose by more than 6 hours of the time you usually take it, wait and then take the next dose at the regularly scheduled time.


What side effects can etravirine cause?

Etravirine can cause serious, life-threatening side effects. These include severe rash and allergic reactions. (See the WARNING above.)

Other possible side effects of etravirine include:

Tell your health care provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of etravirine. Ask your health care provider or pharmacist for more information on possible side effects of etravirine.


How should etravirine be stored?


Where can I find more information about etravirine?

More information about etravirine is available:


Manufacturer Information


Janssen Pharmaceuticals, Inc.
800-526-7736

The above Patient Version drug summary is based on the following FDA label(s): Tablet.




This article was provided by AIDSinfo. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art37550.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.